by Maya Caldwell | Jun 19, 2018
On June 18th, 2018 the US Food and Drug Administration (FDA) announced it would use congressional funding to update generic drug labels. Furthermore, FDA plans to begin with cancer drugs. In a blog post, FDA Commissioner Scott Gottlieb said the agency would use $37.6...
by Maya Caldwell | Jun 13, 2018
With only three months remaining in Fiscal Year 2018, the US Food and Drug Administration (FDA) is on target to approve a similar number of generic drugs as it did in Fiscal 2017. Fiscal 2018 marks the first year of the agency’s second generic drug user fee program in...
by Maya Caldwell | Jun 13, 2018
FDA Commissioner Scott Gottlieb, M.D., released a statement on June 12, 2018 discussing new agency efforts. Throughout the statement, Gottlieb acknowledges how biological advancements have led to the development and FDA approval of targeted treatments for patients...
by Maya Caldwell | Jun 8, 2018
Robert Seevers, Senior Advisor at Pearl Pathways, will present at the 122nd AFDO Annual Educational Conference occurring in Burlington, VT on June 9-13. As a member of the USP Expert Committee on Packaging, Storage, and Distribution, Robert Seevers will provide an...
by Maya Caldwell | Jun 7, 2018
The Food and Drug (FDA) Commissioner Scott Gottlieb released a statementon new policies aimed to prevent the practice of using certain agency requirements to block timely generic drug entry. The release came two weeks after the FDA called outbrand pharmaceutical...
